Tag: <span>SARS-CoV-2 virus</span>

Home / SARS-CoV-2 virus
How a SARS-CoV-2 virus protein damages the heart
Post

How a SARS-CoV-2 virus protein damages the heart

by University of Maryland School of Medicine When the SARS-CoV-2 protein Nsp6 is made in a fruit fly heart (center), the heart has structural defects compared to a normal heart without the viral protein (left). When fruit fly hearts with the viral Nsp6 protein are given the metabolism changing drug 2DG (right), the hearts begin...

Evidence of SARS-CoV-2 virus infecting astrocyte cells in the brain
Post

Evidence of SARS-CoV-2 virus infecting astrocyte cells in the brain

by Bob Yirka, Medical Xpress Cortical thickness atrophy after mild COVID-19 infection. Surface-based morphometry by high-resolution 3T MRI (A). Results from the analysis of 81 subjects with confirmed SARS-CoV-2 diagnosis (who had mild respiratory symptoms and did not require hospitalization or oxygen support) compared with 81 healthy volunteers (without a diagnosis of COVID-19). The analysis...

Study suggests SARS-CoV-2 virus enters the brain by using cells in the nose to make nanotube tunnels
Post

Study suggests SARS-CoV-2 virus enters the brain by using cells in the nose to make nanotube tunnels

by Bob Yirka, Medical Xpress SARS-CoV-2 can reach SH-SY5Y neuronal cells from Vero E6 permissive cells. Infected Vero E6 cells (donor cells) were cocultured with SH-SY5Y neuronal cells previously stably transfected with a vector that expresses mCherry (acceptor cells). Coculture was fixed at 24 and 48 hours. (A to G) Confocal micrographs showing 48 hours...

Post

New virology data shows the investigational COVID antiviral drug molnupiravir eliminates actively infectious SARS-CoV-2 virus by day 3 of starting therapy

EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES New data to be presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) shows that participants taking the new anti-COVID drug molnupiravir eliminate actively infectious SARS-CoV-2 virus by day 3 of starting therapy, while many participants who received placebo...

COVID pandemic second anniversary: Three things we got wrong, and three things to watch out for
Post

COVID pandemic second anniversary: Three things we got wrong, and three things to watch out for

by Adrian Esterman, The Conversation Credit: Pixabay/CC0 Public Domain Exactly two years ago, on March 11 2020, the World Health Organization (WHO) declared COVID-19 a global pandemic. This was two months after there were reports of a mystery virus infecting people in Wuhan, the most populous city in central China. Early reports said the virus didn’t appear to...

Preliminary research suggests SARS-CoV-2 virus less infectious within five minutes of exposure to air
Post

Preliminary research suggests SARS-CoV-2 virus less infectious within five minutes of exposure to air

by Bob Yirka , Medical Xpress Credit: Pixabay/CC0 Public Domain In a study that has not yet been peer-reviewed or accepted for publication, researchers at Bristol University in the U.K. have found evidence that suggests the SARS-CoV-2 virus becomes less infectious within five minutes of exposure to air. The team has published a paper on...

Post

Sensor based on quantum physics could detect SARS-CoV-2 virus

Mathematical simulations show the new approach may offer faster, cheaper, and more accurate detection, including identifying new variants. A novel approach to testing for the presence of the virus that causes Covid-19 may lead to tests that are faster, less expensive, and potentially less prone to erroneous results than existing detection methods. Though the work,...

COVID-19 Breakthrough: Scientists Discover How the SARS-CoV-2 Virus Evades Our Immune System
Post

COVID-19 Breakthrough: Scientists Discover How the SARS-CoV-2 Virus Evades Our Immune System

By GRACIE BLACKWELL, TEXAS A&M COLLEGE OF MEDICINE DECEMBER 8, 2021 The expression of the immune response gene ??NLRC5 (red purple) is suppressed in SARS-CoV-2 (green) infected cells. Credit: Koichi Kobayashi A discovery by researchers at the Texas A&M College of Medicine could lead to new therapies to prevent the virus from proliferating in the human body....

Study finds the SARS-CoV-2 virus can infect the inner ear
Post

Study finds the SARS-CoV-2 virus can infect the inner ear

by Massachusetts Institute of Technology Transmission electron micrograph of SARS-CoV-2 virus particles, isolated from a patient. Image captured and color-enhanced at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID Many COVID-19 patients have reported symptoms affecting the ears, including hearing loss and tinnitus. Dizziness and balance problems can also occur, suggesting...

Existing drug is shown to inhibit SARS-CoV-2 virus
Post

Existing drug is shown to inhibit SARS-CoV-2 virus

by Emily Ayshford,  University of Chicago Creative rendition of SARS-CoV-2 particles (not to scale). Credit: National Institute of Allergy and Infectious Diseases, NIH A new University of Chicago study has found that the drug masitinib may be effective in treating COVID-19. The drug, which has undergone several clinical trials for human conditions but has not yet...

  • 1
  • 2